View Post

New Evidence on Relative Effectiveness of Adjuvanted Seasonal Influenza Vaccine in Seniors

In Influenza Vaccine News by Influenza Vaccine

A worldwide leader in influenza prevention announced the publication of new real-world evidence (RWE) that demonstrated an MF59® adjuvanted, trivalent influenza vaccine (aTIV) was more effective than a standard-dose, non-adjuvanted trivalent seasonal vaccine in preventing influenza-related medical office visits and hospitalizations in seniors during the 2017-2018 influenza season in the USA.
Adding MF59® adjuvant to an influenza vaccine is designed to enhance the immune response to the influenza strains contained in the vaccine in adults 65 years and older.

View Post

Flu Shot and COVID-19 Vaccine Combo Launches Phase 1 Study

In Influenza Vaccine News by Influenza Vaccine

As influenza viruses approach the Northern Hemisphere during the COVID-19 pandemic, many people are questioning which flu shot will perform best with the pending coronavirus vaccines becoming available.
Two companies believe they have a solution to this pending quandary.  
Massachusetts-based Vaxess Technologies has formed a partnership with the Taiwanese pharmaceutical company, Medigen Vaccine Biologics to develop a combined COVID-19 and quadrivalent seasonal influenza vaccine, delivered via the novel MIMIX patch system.

View Post

Gen X'ers Have Different Influenza Antibodies

In Influenza Vaccine News by Influenza Vaccine

Penn Medicine researchers have found that those born in the late 1960s and the 1970s may be in a perpetual state of H3N2 influenza virus susceptibility, because their antibodies bind to H3N2 viruses, but fail to prevent infections.
According to a new study led by Scott Hensley, Ph.D., an associate professor of microbiology at the Perelman School of Medicine in Pennsylvania, it is possible that the presence of high levels of non-neutralizing antibodies in middle-aged adults has contributed to the continued persistence of H3N2 viruses in the human population.

View Post

Will This Year’s Seasonal Influenza Overtake Coronavirus?

In Influenza Vaccine News by Influenza Vaccine

‘The fight against the COVID-19 pandemic may become more difficult as we enter the fall and winter flu season,’ sate Francis S. Collins, M.D., Ph.D., Director, National Institutes of Health (NIH). 
‘Each year influenza causes a surge in hospitalizations, and in combination with COVID-19, is a serious concern for healthcare systems across the USA,’ said Dr. Collins in a September 9, 2020 testimony.

View Post

Where Did Last Year’s Flu Season Go

In Influenza Vaccine News by Influenza Vaccine

In the USA during Week #34 of the U.S. CDC influenza reporting period, about 1% of patient visits reported through the Outpatient Influenza-like Illness Surveillance Network (ILINet) were due to influenza-like illness (ILI). 
This percentage reported on August 28, 2020, is below the national baseline of 2.4%.
Additionally, based on the National Center for Health Statistics (NCHS) mortality surveillance data, 6.2% of the deaths occurring during the week ending August 22, 2020 (Week #34) were due to Pneumonia and Influenza (P&I).